# Effect of Omalizumab in the Skin of Food Allergy Patients

> **NCT06618963** · PHASE4 · RECRUITING · sponsor: **National Jewish Health** · enrollment: 40 (estimated)

## Conditions studied

- Food Allergy
- Food Allergy in Children

## Interventions

- **DRUG:** Omalizumab Injection

## Key facts

- **NCT ID:** NCT06618963
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618963, "Effect of Omalizumab in the Skin of Food Allergy Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06618963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*